Vivo Bio Tech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

37.59

-0.11 (-0.29%)

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Biotechnology

37.59

-0.11 (-0.29%)
16:01 Dec 27

Quality

68/100
High Financial Strength

Valuation

87/100
Affordable Valuation

Technical

30/100
Technically Bearish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	51.78	51.39	52.23	45.45	46.78
Operating Expenses +	34.11	35.58	30.73	24.36	25.06
Raw Material	9.91	7.97	4.93	4.65	4.69
Increase Decrease in Cost	-2.7	3.47	1.84	-0.8	0.46
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	8.57	9.42	13.52	10.68	11.41
Miscellaneous Expenses	38.15	30.66	20.3	19.13	8.5
Operating Profit	17.67	15.81	21.5	21.09	21.72
Other Income	0.08	0.1	0.04	0.04	4.68
Depreciation	5.59	7.45	9.27	9.29	9.23
Interest	3.53	3.99	7.65	7.78	7.72
Profit before tax and exceptio..	8.62	4.47	4.62	4.06	9.45
Exceptional Items	0	0	0	0	0
PBT	8.62	4.47	4.62	4.06	9.45
Provision for Taxation	2.94	2.27	1.97	1.53	1.98
Net Profit	5.68	2.2	2.65	2.53	7.46
NET Profit after MI	5.68	2.2	2.65	2.53	7.46
EPS	4.23	1.56	1.78	1.7	5.01
Operating Profit Margin (%)	34.13	30.76	41.16	46.4	46.43
Net Profit Margin (%)	10.97	4.28	5.07	5.57	15.95

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	42.10	42.10	42.10	42.10	42.10
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	57.90	57.90	57.90	57.90	57.90
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.00	0.00	0.00